Skip to main content

Peer Review reports

From: Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction

Original Submission
5 Mar 2005 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Nov 2005 Editorially accepted
2 Nov 2005 Article published 10.1186/1472-6904-5-5

You can find further information about peer review here.

Back to article page